{"transactions":[{"id":2217830,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Options (right to buy)","published_at":"2022-07-01T19:13:03.000Z","date":"2022-03-16","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Retired from position as Executive Vice President, Chief Development & Operations Officer on May 31, 2022.  All unvested equity awards forfeited upon retirement."}],"balance_after":0,"derivative":{"exercise_price":2.59,"exercise_date":"2026-03-16","expiration_date":"2032-03-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-040113","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919122040113/doc4.xml","form_type":"4"}},{"id":2217829,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Options (right to buy)","published_at":"2022-07-01T19:13:03.000Z","date":"2021-03-17","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Retired from position as Executive Vice President, Chief Development & Operations Officer on May 31, 2022.  All unvested equity awards forfeited upon retirement."}],"balance_after":0,"derivative":{"exercise_price":3.22,"exercise_date":"2025-03-17","expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-040113","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919122040113/doc4.xml","form_type":"4"}},{"id":2217828,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2022-07-01T19:13:03.000Z","date":"2022-05-31","kind":"other","acquired":false,"shares":33500,"price":2.09,"value":70015.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Retired from position as Executive Vice President, Chief Development & Operations Officer on May 31, 2022.  All unvested equity awards forfeited upon retirement."}],"balance_after":129618,"source":{"system":"sec-edgar","filing":"0001209191-22-040113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919122040113/doc4.xml","form_type":"4"}},{"id":2288137,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Options (right to buy)","published_at":"2022-04-29T17:09:13.000Z","date":"2022-03-16","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting on March 16, 2026."}],"balance_after":5000,"derivative":{"exercise_price":2.59,"exercise_date":"2026-03-16","expiration_date":"2032-03-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-026150","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919122026150/doc4.xml","form_type":"4"}},{"id":2672558,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Options (right to buy)","published_at":"2021-06-11T21:11:29.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% vesting on March 17, 2025."}],"balance_after":5000,"derivative":{"exercise_price":3.22,"exercise_date":"2025-03-17","expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-039925","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919121039925/doc4.xml","form_type":"4"}},{"id":2672557,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2021-06-11T21:11:29.000Z","date":"2021-03-17","kind":"tax_withholding","acquired":false,"shares":2870,"price":3.22,"value":9241.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":168118,"source":{"system":"sec-edgar","filing":"0001209191-21-039925","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919121039925/doc4.xml","form_type":"4"}},{"id":3174603,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2020-04-17T21:14:49.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":25000,"price":3.56,"value":89000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock award will vest 100% on March 23, 2024."}],"balance_after":165988,"source":{"system":"sec-edgar","filing":"0001209191-20-024873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919120024873/doc4.xml","form_type":"4"}},{"id":3174602,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2020-04-17T21:14:49.000Z","date":"2020-03-18","kind":"tax_withholding","acquired":false,"shares":9637,"price":3.53,"value":34018.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":140988,"source":{"system":"sec-edgar","filing":"0001209191-20-024873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919120024873/doc4.xml","form_type":"4"}},{"id":3356797,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2019-11-29T22:24:06.000Z","date":"2019-11-26","kind":"tax_withholding","acquired":false,"shares":3710,"price":4.93,"value":18290.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":154051,"source":{"system":"sec-edgar","filing":"0001209191-19-058440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119058440/doc4.xml","form_type":"4"}},{"id":3426122,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2019-08-30T21:20:01.000Z","date":"2019-08-26","kind":"tax_withholding","acquired":false,"shares":1850,"price":5.63,"value":10415.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":157761,"source":{"system":"sec-edgar","filing":"0001209191-19-047852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119047852/doc4.xml","form_type":"4"}},{"id":3506643,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2019-05-31T21:13:21.000Z","date":"2019-05-21","kind":"tax_withholding","acquired":false,"shares":1850,"price":6.3,"value":11655.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":159611,"source":{"system":"sec-edgar","filing":"0001209191-19-033697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119033697/doc4.xml","form_type":"4"}},{"id":3581997,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2019-03-22T21:22:12.000Z","date":"2019-03-22","kind":"tax_withholding","acquired":false,"shares":2343,"price":5.62,"value":13167.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":161461,"source":{"system":"sec-edgar","filing":"0001209191-19-021049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119021049/doc4.xml","form_type":"4"}},{"id":3581996,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2019-03-22T21:22:12.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":25000,"price":5.98,"value":149500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 18, 2023."}],"balance_after":163804,"source":{"system":"sec-edgar","filing":"0001209191-19-021049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119021049/doc4.xml","form_type":"4"}},{"id":3984190,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2018-03-23T21:45:59.000Z","date":"2018-03-23","kind":"tax_withholding","acquired":false,"shares":2557,"price":6.7,"value":17131.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":130304,"source":{"system":"sec-edgar","filing":"0001209191-18-021483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118021483/doc4.xml","form_type":"4"}},{"id":3984189,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2018-03-23T21:45:59.000Z","date":"2018-03-23","kind":"grant","acquired":true,"shares":25000,"price":6.7,"value":167500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 20, 2022."}],"balance_after":132861,"source":{"system":"sec-edgar","filing":"0001209191-18-021483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118021483/doc4.xml","form_type":"4"}},{"id":4356243,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2017-04-07T20:53:52.000Z","date":"2017-04-07","kind":"tax_withholding","acquired":false,"shares":3582,"price":6.45,"value":23103.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 10,000 shares during March 2017."}],"balance_after":107861,"source":{"system":"sec-edgar","filing":"0001209191-17-026299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117026299/doc4.xml","form_type":"4"}},{"id":4356242,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":125728,"kind":"person","name":"Pavliv Leo","position":1,"cik":"0001408593","reported_name":"Pavliv Leo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Chief Development Off."}}],"security":"Common Stock","published_at":"2017-04-07T20:53:52.000Z","date":"2017-04-07","kind":"grant","acquired":true,"shares":10000,"price":6.45,"value":64500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 17, 2021."}],"balance_after":111443,"source":{"system":"sec-edgar","filing":"0001209191-17-026299","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117026299/doc4.xml","form_type":"4"}}]}